Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209748) titled 'sCD163 in HELLP Syndrome' on Sept. 30.
Study Type: Observational 
Primary Sponsor: Assiut University 
Condition: 
HELLP Syndrome Complicating Pregnancy
Intervention: 
Diagnostic Test: sCD163 level
Recruitment Status: Not recruiting 
Date of First Enrollment: December 1, 2025 
Target Sample Size: 70 
To know more, visit https://clinicaltrials.gov/study/NCT07209748
Published by HT Digital Content Services with permission from Health Daily Digest....
		
			